Download - Glenmark
Download - Glenmark
Download - Glenmark
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Particulars 31 March 2011<br />
Deferred income tax liabilities - Non-current<br />
Other current assets 25.14<br />
Difference in depreciation on Property, plant and equipment 1,451.16<br />
1,476.30<br />
Net deferred income tax asset 1,081.36<br />
In assessing the reliability of deferred income tax assets, management considers whether it is more likely than not that<br />
some portion or all of the deferred income tax assets will be realised. The ultimate realisation of deferred income tax assets<br />
is dependent upon the generation of future taxable income during the periods in which the temporary differences become<br />
deductible. The amount of the deferred income tax assets considered realisable, however, could be reduced in the near<br />
term if estimates of future taxable income during the carry forward period are reduced.<br />
NOTE O - EQUITY AND RESERVES<br />
a) Ordinary shares<br />
The Company presently has only one class of ordinary shares. For all matters submitted to vote in the shareholders<br />
meeting, every holder of ordinary shares, as reflected in the records of the Company on the date of the shareholders’<br />
meeting, has one vote in respect of each share held. All shares are equally eligible to receive dividends and the<br />
repayment of capital in the event of liquidation of the Company.<br />
The Company has an authorised share capital of 350,000,000 equity shares of ` 1 each.<br />
b) Dividends<br />
Indian statutes mandate that dividends be declared out of distributable profits only after the transfer of up to 10<br />
percent of net income computed in accordance with regulations to a general reserve. Should the Company declare<br />
and pay dividends, such dividends are required to be paid in INR to each holder of equity shares in proportion to the<br />
number of shares held.<br />
The Company had declared dividend payout of ` 0.40 per share.<br />
c) Reserves<br />
Additional paid-in capital – The amount received by the Company over and above the par value of shares issued<br />
(share premium) is shown under this head.<br />
Statutory reserves – The Capital redemption reserve has been created as per the requirement of Section 80 of The<br />
Companies Act, 1956. Such reserve is not currently available for distribution to the shareholders.<br />
Currency translation reserve – Assets and liabilities of foreign subsidiaries are translated into INR at the rate of<br />
exchange prevailing as at the date of statement of financial position. Revenue and expenses are translated into INR<br />
by averaging the exchange rates prevailing during the period. The exchange difference arising out of the year-end<br />
translation is being debited or credited to Currency translation reserve account.<br />
Accumulated earnings – Accumulated earnings include all current and prior period results as disclosed in the<br />
income statement.<br />
Stock compensation reserve – Stock compensation reserve consists of employee compensation cost allocated over<br />
the vesting period of options granted to employees. Such cost is recognised in income statement and is credited to the<br />
reserve. Upon exercise of options, such reserves are reclassified to other components of equity.<br />
NOTE P - OPERATING REVENUE<br />
Operating revenue comprises the following:<br />
Particulars<br />
Year ended<br />
31 March 2011<br />
Sale of goods and out licensing of intangible assets 29,473.98<br />
Income from services 16.72<br />
Total 29,490.70<br />
NOTE Q - OTHER INCOME<br />
Other income comprises the following:<br />
Particulars<br />
Year ended<br />
31 March 2011<br />
Profit on sale of property, plant and equipment 3.52<br />
Exchange gain, others 1,300.47<br />
Lease rent 2.20<br />
Others 98.99<br />
Total 1,405.18<br />
98<br />
GLENMARK PHARMACEUTICALS LIMITED